NxStage Medical (NXTM - Get Report) is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. This stock is trading up 3.9% at $21.01 in recent trading.
Today's Volume: 991,000Average Volume: 512,889 Volume % Change: 93% From a technical perspective, NXTM has started to trigger a major breakout trade today now that this stock is moving above some past overhead resistance at $20.05 to $20.13 on heavy volume. Traders should continue to look for long biased trades in NXTM as long as the stock can continue to trend above those key breakout levels. I would target a run back towards the next significant overhead resistance at $24 in the near future, if those breakout levels hold.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts